Ingrid Delaet
General Counsel at NEUROCRINE BIOSCIENCES, INC.
Net worth: 1 M $ as of 2024-06-29
Profile
Ingrid Delaet is currently the Chief Regulatory Officer at Neurocrine Biosciences, Inc. She previously worked as the Senior Vice President-Regulatory Affairs at Intercept Pharmaceuticals, Inc. from 2016 to 2021.
Dr. Delaet holds graduate and doctorate degrees from Université Libre de Bruxelles.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-06-30 | 7,507 ( 0.01% ) | 1 M $ | 2024-06-29 |
Ingrid Delaet active positions
Companies | Position | Start |
---|---|---|
NEUROCRINE BIOSCIENCES, INC. | General Counsel | 2020-12-31 |
Former positions of Ingrid Delaet
Companies | Position | End |
---|---|---|
INTERCEPT PHARMACEUTICALS, INC. | General Counsel | 2020-12-31 |
Training of Ingrid Delaet
Université Libre de Bruxelles | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
- Stock Market
- Insiders
- Ingrid Delaet